Top news of May: Elijah’s Law, WHIM syndrome, gas stoves, more
Click Here to Manage Email Alerts
Healio compiled the most-read news in allergy, asthma and immunology posted in May.
Highlights included state legislation crafted to reduce risks for anaphylaxis, the impact of gas stoves on children with asthma, research presented at the American Thoracic Society International Conference, career advice from our Women in Allergy series, and more.
Maryland Governor signs Elijah’s Law, protecting children with allergies
Maryland lawmakers passed HB1195, or Elijah’s Law, which requires state departments to develop a set of guidelines for childcare centers to reduce the risk for anaphylactic reactions to food allergen. Read more.
FDA approves mavorixafor for WHIM syndrome
The FDA has approved mavorixafor for treating warts, hypogammaglobulinemia, infections and myelokathexis (WHIM) syndrome, a rare and chronic primary immunodeficiency, X4 Pharmaceuticals president and CEO Paula Ragan, PhD, told Healio. Read more.
Nitrogen dioxide from gas stoves associated with thousands of asthma cases in the US
Increased exposure to nitrogen dioxide from U.S. stoves may be responsible for approximately 50,000 cases of current pediatric asthma, with marginalized groups incurring more exposure than the national average, said researchers from the Stanford Doerr School of Sustainability. Read more.
VIDEO: Allergist advises younger self not to ‘sweat the small stuff’
Priya J. Bansal, MD, FAAAAI, FACAAI, speaks with Christina E. Ciaccio, MD, MSc, about the advice she would give her younger self when she became an allergist, as part of Healio’s Women in Allergy video corner series. Read more.
Exacerbation patterns indicate potential benefits with stepping up asthma therapy
Patients with asthma exacerbations despite inhaled corticosteroids and long-acting beta 2 agonists may benefit from stepping up treatment, said Stephen G. Noorduyn, MSc, global director, value evidence and outcomes, GSK, said at the American Thoracic Society International Conference. Read more.
Asthma, type 2 inflammation associated with coronary artery disease
The odds ratio for coronary artery disease among patients with asthma and evidence of type 2 inflammation was 1.117, which researchers considered a significant association, Christa McPhee, MD, said at the American Thoracic Society International Conference. Read more.
Anti-TSLP therapy reduces inflammation in moderate to severe asthma
Patients treated with high doses of AZD8630/AMG 104 (Tezspire; Amgen, AstraZeneca), which is a fragment antibody against thymic stromal lymphopoietin, experienced a statistically significant 23% reduction in fractional exhaled nitric oxide, researchers said at the American Thoracic Society International Conference. Read more.
Researcher seeks to better understand how eosinophilic GI disorders impact women’s health
Jenny Huang, MD, who has been diagnosed with eosinophilic gastritis herself, is studying how eosinophilic esophagitis and other eosinophilic gastrointestinal disorders impact women during pregnancy because their disease courses among these patients are not well understood. Read more.
Public websites show low accuracy in predicting pollen counts in five U.S. cities
None of the four websites that were analyzed consistently provided accurate pollen counts compared with data from the National Allergy Bureau, researchers from the University of Arizona College of Medicine wrote in The Journal of Allergy and Clinical Immunology: In Practice. Also, N. Sabrina Idrose, PhD, MSc, shares her Perspective. Read more.
Prompts in electronic health records improve guideline-based asthma care
Prompts with guideline-based decision support and education about guideline-based care led to preventive action for 91% of children in an intervention group, compared with 74% in a group that did not have these prompts, Marina Reznik, MD, MS, of Children’s Hospital at Montefiore, told Healio. Read more.